Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bearish
IKang Healthcare Group (ADR)
Watchlist
Sell-Side Analysts Resurface: What to Think?
Event-Driven
251 Views
21 Dec 2017 16:24
iKang Healthcare Group (ADR) (KANG US) recently reported its Q2FY2017 (September 2017) results. Both volume and revenue growth accelerated from Q1...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 2-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Japan
India
Equity Bottom-Up
Sell / Short Ideas
Index Rebalance
Event-Driven
Philippines
South Korea
China
Unpaywalled Insights
Trending Insights
More »
[Quiddity Index] Van Eck Gold Miners ETF (GDX) - Benchmark Change for Sep Rebal - $2.8bn One Way
Synopsys’ $35 Billion Acquisition of Ansys Closing: Major Index Changes Triggered
US Inflation Creeps In Quietly
Ohayo Japan | Wall Street Mixed as Inflation Pressures Mount, Bank Earnings Disappoint
ZEEKR (ZK US): Geely Auto’s Binding Offer a Done Deal
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
IKang Healthcare Buyout: The Ground Is Shakier
07 Sep 2018
Updated Proxy Filed and Q4 Results Released
27 Jun 2018
IKang: Endgame Approaching, But Fair Price Is Distant
26 Mar 2018
Sell-Side Analysts Resurface: What to Think?
21 Dec 2017
The Elephant in the Room
27 Sep 2017
No News Is, Well, No News
17 Jul 2017
Roundup of the Medical Examination Sector
12 Apr 2017
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.3
x